Children will be evaluated by the Visual Analog Scale of pain and children who had received ketamine should be lower scores when compared to children who had received placebo. These children are expected to ask less times for analgesic medication;
Comparison of Peritonsillar Infiltration of Tramadol Ketamine and Placebo on Pediatric Posttonsillectomy Pain
Brief Summary
Intervention / Treatment
-
Tramadol (DRUG)Patients will receive injections in peritonsillar fossa of tramadol (2 mg/kg-2 ml)
-
Ketamine (DRUG)Patients will receive injections in peritonsillar fossa of ketamine prior to surgery
-
Placebos (DRUG)Patients will receive 2mL of saline solution in peritonsillar fossa prior to surgery
Condition or Disease
- Sleep Disorder; Breathing-Related
- Pain, Postoperative
- Child, Only
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Unknown status |
Study results: | No Results Available |
Age: | 3 Years to 11 Years |
Enrollment: | 108 (ESTIMATED) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Treatment |
MaskingPatients admitted for tonsillectomy were randomized into 3 groups by means of sealed envelopes. The envelope selected by the caregiver will be open by the registered nurse, who will prepare the infiltration. Neither the surgeon, anesthesiologist the caregiver nor the patient will see what is inside the envelope. The register of the envelope number and patient data will be done by the statistical group TRIPLE:
|
Clinical Trial Dates
Start date: | Jul 01, 2017 | ESTIMATED |
---|---|---|
Primary Completion: | Jul 01, 2017 | ESTIMATED |
Completion Date: | May 01, 2019 | ESTIMATED |
Study First Posted: | Mar 01, 2017 | ACTUAL |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | May 01, 2017 |
Sponsors / Collaborators
Location
The study was approved by the Ethics Committee of the University. The consents will be taken from all parents. Patients will be randomized from seald envelope into tramadol, ketamine or control (serum physiologic) to receive the preincisional peritonsillar infiltration before the surgery. There will de 36 patients in each group. The study drug is supplied of a liquid identical in color and volume. All surgeons, anesthesiologists, nurses, patients and parents will be blinded to study group until the end of the study All children will receive a premedication including midazolam hydrochloride (0.5 mg/kg; maximum dose, 20 mg) followed by a standard general inhalational anesthetic (50% O2-N2O and 8% sevoflurane). Children also received 0.1 mg/kg of fentanyl citrate and 0.2 mg/kg mivacurium intravenously. After the intubation maintenance anesthesia will be keep with nitrous oxide (50%) in oxygen and sevoflurane. All patients will receive the peritonsillar injection of the study drug before the excision of the anesthesia. Tramadol group will receive 2 mg/kg (2 ml), ketamine group 0.5 mg/kg (2cc), control group 2 ml of serum physiologic. All infiltrations will be through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. After the infiltration surgeons will wait 3 min for tonsillectomy. The same standard blunt dissection will be performed to all children by the same surgeon. During the operation heart rate oxygen saturation, average blood pressure, respiration rates will be recorded in every 5 min. Operation, anesthesia times will also be recorded. Postoperatively pain, nausea, vomiting, sedation scores, the existence of dysphagia, bleeding were recorded at 2, 6, 12, 24 h postoperatively. Children's pain scores will be measured by using Visual Analogue Scale (VAS).If the pain score is greater than 5, Ibuprofen will be given to children. Pains with the request for analgesic requirements, the time of analgesia requirement, patient satisfaction will be also recorded.
Data analysis will be performed by using SPSS for Windows. The relationship between categorical variables will be test by Chi-square test and Anova test will be performed to compare groups according to continuous variables. Also LSD test will be used to detect subgroup differences. p Values higher than 0.05 will be considered as significant. Mean and standard deviations and percentages will be given as descriptive statistics.
Participant Groups
-
Tramadol group will receive 2 mg/kg (2 ml) through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. The depth of the infiltration will be as superficial as 3 mm of needle injected and ballooned out the submucosal tissues of the tonsillar pillar, intratonsillar injection as avoided.
-
Ketamine group will receive 0.5 mg/kg (2cc) through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. The depth of the infiltration will be as superficial as 3 mm of needle injected and ballooned out the submucosal tissues of the tonsillar pillar, intratonsillar injection as avoided.
-
Placebo group will receive 2mL of saline solution through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. The depth of the infiltration will be as superficial as 3 mm of needle injected and ballooned out the submucosal tissues of the tonsillar pillar, intratonsillar injection as avoided.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 3 |
Maximum Age: | 11 |
Age Groups: | Child |
Healthy Volunteers: | Yes |
* Sleep disordered breathing
* ASA I-II
Exclusion Criteria:
* ASA III-IV physical status
* Coagulation disturbances
* Presence of relevant drug allergies
* pulmonary and cardiac diseases
* Craniofacial anomalies
* Mental diseases
* Genetic disorders
* Peritonsillar abscess formation
* Regular use of analgesics 24 h prior to surgery
Primary Outcomes
Secondary Outcomes
-
Children will be evaluated by the Visual Analog Scale of pain and children who had received tramadol should be lower scores when compared to children who had received placebo. These children are expected to ask less times for analgesic medication;
More Details
NCT Number: | NCT03067103 |
---|---|
Other IDs: | JASC1 |
Study URL: | https://clinicaltrials.gov/study/NCT03067103 |